Methods and compositions for treating a renal disease condition in a subject
Methods for treating a renal associated disease condition in a subject are provided. The subject methods are characterized by modulating at least one portion of the subject's autonomic nervous system in a manner effective to treat a renal condition in the subject. Specifically, the methods may include modulating, e.g., increasing, a parasympathetic/sympathetic activity ratio in the subject. Also provided are compositions, kits and systems for practicing the subject methods.
1. A method of preventing contrast-induced nephropathy in a subject, said method comprising:
evaluating the subject for sympathetic bias induced by administration of a contrast agent; and
modulating at least one portion of the autonomic nervous system in said evaluated subject having sympathetic bias by selectively administering a beta blocker or a renin inhibitor to the kidney by intrarenal infusion, in a manner effective to prevent said contrast-induced nephropathy,
wherein said modulating comprises increasing parasympathetic activity and decreasing the sympathetic bias in said subject to prevent contrast-induced nephropathy in said subject.
2. The method of claim 1 , wherein said method further comprises at least applying electrical energy from an electrical energy applying device to said at least one portion of said autonomic nervous system.
3. The method of claim 2 , wherein said method comprises increasing parasympathetic activity.
4. The method of claim 2 , wherein said method comprises decreasing sympathetic activity.
5. The method of claim 2 , wherein said method comprises increasing parasympathetic activity and decreasing sympathetic activity.
6. The method of claim 1 , wherein said contrast-induced nephropathy is iodine-based contrast-induced nephropathy.
7. A computer-readable medium with stored programming embodying an algorithm for modulating at least one portion of the autonomic nervous system of a subject in accordance with the method of claim 1 .
8. A system comprising:
(a) a computer-readable medium with stored programming embodying an algorithm-for modulating at least one portion of the autonomic nervous system of a subject according to a method of claim 1 ;
(b) an effective amount of the pharmacological agent, and
(c) a drug delivery device.
9. A kit comprising:
a pharmacological agent; and
instructions for administering said pharmacological agent to a subject according to the method of claim 1 ; and
a drug delivery device for selectively administering said pharmacological agent to a kidney by intrarenal infusion, wherein the pharmacological agent is a beta blocker or a renin inhibitor.
10. The method according to claim 1 , wherein said modulating further comprises increasing said parasympathetic activity in said subject to result in parasympathetic bias in said portion of the autonomic nervous system.
11. The method of claim 1 , wherein the pharmacological agent is a renin inhibitor and the renin-inhibitor is aliskiren.
12. The method of claim 11 , wherein said aliskiren is administered by weekly infusion.
13. The kit of claim 9 , wherein the pharmacological agent is a beta blocker and the beta blocker is metoprolol.
14. The method of claim 1 , wherein the pharmacological agent is a beta blocker.
15. The method of claim 14 , wherein the beta blocker is metoprolol.
16. The method of claim 1 , wherein modulating at least one portion of the autonomic nervous system in said evaluated subject having sympathetic bias comprises selectively administering a beta blocker to the kidney by intrarenal infusion, in a manner effective to prevent said contrast-induced nephropathy.
17. The method according to claim 16 , wherein the beta blocker is the sole active agent selectively administered to the kidney to modulate the at least one portion of the autonomic nervous system and prevent the contrast-induced nephropathy.
18. The method of claim 1 , wherein modulating at least one portion of the autonomic nervous system in said evaluated subject having sympathetic bias comprises selectively administering a renin inhibitor to the kidney by intrarenal infusion, in a manner effective to prevent said contrast-induced nephropathy.
19. The method according to claim 18 , wherein the renin inhibitor is the sole active agent selectively administered to the kidney to modulate the at least one portion of the autonomic nervous system and prevent the contrast-induced nephropathy.